| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hyperinsulinism | D006946 | 27 associated lipids |
| Endotoxemia | D019446 | 27 associated lipids |
| Neuralgia | D009437 | 28 associated lipids |
| Obesity | D009765 | 29 associated lipids |
| Catalepsy | D002375 | 30 associated lipids |
| Neurodegenerative Diseases | D019636 | 32 associated lipids |
| Memory Disorders | D008569 | 33 associated lipids |
| Ventricular Dysfunction, Left | D018487 | 33 associated lipids |
| Peripheral Nervous System Diseases | D010523 | 33 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Iversen L | Pharmacology. Endogenous cannabinoids. | 1994 | Nature | pmid:7990950 |
| Di Marzo V et al. | Formation and inactivation of endogenous cannabinoid anandamide in central neurons. | 1994 | Nature | pmid:7990962 |
| Zygmunt PM et al. | Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. | 1999 | Nature | pmid:10440374 |
| di Tomaso E et al. | Brain cannabinoids in chocolate. | 1996 | Nature | pmid:8751435 |
| RodrÃguez de Fonseca F et al. | An anorexic lipid mediator regulated by feeding. | 2001 | Nature | pmid:11700558 |
| Cravatt BF et al. | Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. | 1996 | Nature | pmid:8900284 |
| Calignano A et al. | Bidirectional control of airway responsiveness by endogenous cannabinoids. | 2000 | Nature | pmid:11081515 |
| Mechoulam R | Todd's achievement. | 1997 | Nature | pmid:9126725 |
| Wagner JA et al. | Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. | 1997 | Nature | pmid:9394002 |
| Balas L et al. | Synthesis of a photoactivatable probe of the anandamide re-uptake. | 2005 | Nat. Prod. Res. | pmid:15938150 |
| Kim J and Alger BE | Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. | 2004 | Nat. Neurosci. | pmid:15184902 |
| Marsicano G and Chaouloff F | Moving bliss: a new anandamide transporter. | 2012 | Nat. Neurosci. | pmid:22193249 |
| Self DW | Anandamide: a candidate neurotransmitter heads for the big leagues. | 1999 | Nat. Neurosci. | pmid:10204533 |
| Giuffrida A et al. | Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. | 1999 | Nat. Neurosci. | pmid:10204543 |
| Kim J and Alger BE | Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. | 2010 | Nat. Neurosci. | pmid:20348918 |
| Maccarrone M et al. | Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. | 2008 | Nat. Neurosci. | pmid:18204441 |
| Di Marzo V | Anandamide serves two masters in the brain. | 2010 | Nat. Neurosci. | pmid:21102567 |
| Clapper JR et al. | Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism. | 2010 | Nat. Neurosci. | pmid:20852626 |
| Di Marzo V | Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. | 2011 | Nat. Neurosci. | pmid:21187849 |
| Chávez AE et al. | TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. | 2010 | Nat. Neurosci. | pmid:21076423 |
| Fu J et al. | A catalytically silent FAAH-1 variant drives anandamide transport in neurons. | 2012 | Nat. Neurosci. | pmid:22101642 |
| Gerdeman GL et al. | Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. | 2002 | Nat. Neurosci. | pmid:11976704 |
| Fields HL and Meng ID | Watching the pot boil. | 1998 | Nat. Med. | pmid:9734389 |
| Stock K et al. | Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1. | 2012 | Nat. Med. | pmid:22820645 |
| Piomelli D | THC: moderation during implantation. | 2004 | Nat. Med. | pmid:14702623 |
| Kathuria S et al. | Modulation of anxiety through blockade of anandamide hydrolysis. | 2003 | Nat. Med. | pmid:12461523 |
| Jourdan T et al. | Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. | 2013 | Nat. Med. | pmid:23955712 |
| Bátkai S et al. | Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. | 2001 | Nat. Med. | pmid:11433348 |
| Nomura DK et al. | Activation of the endocannabinoid system by organophosphorus nerve agents. | 2008 | Nat. Chem. Biol. | pmid:18438404 |
| Long JZ et al. | Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. | 2009 | Nat. Chem. Biol. | pmid:19029917 |
| Voets T et al. | Sensing with TRP channels. | 2005 | Nat. Chem. Biol. | pmid:16408004 |
| Mechoulam R and Ben-Shabat S | From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. | 1999 | Nat Prod Rep | pmid:10331283 |
| Pastuhov SI et al. | Endocannabinoid-Goα signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqα-PKC-JNK signalling. | 2012 | Nat Commun | pmid:23072806 |
| Alpár A et al. | Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. | 2014 | Nat Commun | pmid:25030704 |
| Pryce G et al. | Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors. | 2013 | Mult. Scler. | pmid:23625705 |
| Pisani V et al. | Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients. | 2010 | Mov. Disord. | pmid:20461809 |
| Muccioli GG et al. | The endocannabinoid system links gut microbiota to adipogenesis. | 2010 | Mol. Syst. Biol. | pmid:20664638 |
| Schuel H et al. | Evidence that anandamide-signaling regulates human sperm functions required for fertilization. | 2002 | Mol. Reprod. Dev. | pmid:12237954 |
| Paria BC et al. | The uterus is a potential site for anandamide synthesis and hydrolysis: differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period. | 1996 | Mol. Reprod. Dev. | pmid:8914076 |
| Neumeister A et al. | Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. | 2013 | Mol. Psychiatry | pmid:23670490 |
| Gunduz-Cinar O et al. | Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. | 2013 | Mol. Psychiatry | pmid:22688188 |
| Zhang X et al. | Agonist-dependent potentiation of vanilloid receptor transient receptor potential vanilloid type 1 function by stilbene derivatives. | 2012 | Mol. Pharmacol. | pmid:22328719 |
| Snider NT et al. | A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist. | 2009 | Mol. Pharmacol. | pmid:19171674 |
| Spivak CE et al. | The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. | 2007 | Mol. Pharmacol. | pmid:17628012 |
| Yates ML and Barker EL | Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. | 2009 | Mol. Pharmacol. | pmid:19389920 |
| Mackie K et al. | Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. | 1993 | Mol. Pharmacol. | pmid:8371711 |
| McFarland MJ et al. | RNA interference-mediated knockdown of dynamin 2 reduces endocannabinoid uptake into neuronal dCAD cells. | 2008 | Mol. Pharmacol. | pmid:18436710 |
| Guo J and Ikeda SR | Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. | 2004 | Mol. Pharmacol. | pmid:14978245 |
| Breivogel CS et al. | Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. | 2001 | Mol. Pharmacol. | pmid:11408610 |
| Edgemond WS et al. | Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. | 1998 | Mol. Pharmacol. | pmid:9658204 |